113
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Release Profile of Cardiac Troponin T and Risk Factors of Postoperative Myocardial Injury in Patients Undergoing CABG

, ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Pages 2541-2551 | Published online: 15 Jun 2021

References

  • Lim CC, Cuculi F, van Gaal WJ, et al. Early diagnosis of perioperative myocardial infarction after coronary bypass grafting: a study using biomarkers and cardiac magnetic resonance imaging. Ann Thorac Surg. 2011;92(6):2046–2053. doi:10.1016/j.athoracsur.2011.05.019
  • Kocak EF, Kocak C, Aksoy A, et al. High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery. Cardiovasc J Afr. 2015;26(6):234–241. doi:10.5830/CVJA-2015-052
  • Zhou P, Zhu P, Xiao Z, Lin X, Xu R, Zheng S. Meta-analysis of repeat revascularization of off-pump and on-pump coronary artery bypass surgery. Ann Thorac Surg. 2018;106(2):526–531. doi:10.1016/j.athoracsur.2018.02.068
  • Moon MH, Song H, Wang YP, Jo KH, Kim CK, Cho KD. Changes of cardiac troponin I and operative mortality of coronary artery bypass. Asian Cardiovasc Thorac Ann. 2014;22(1):40–45. doi:10.1177/0218492312468439
  • Sandoval Y, Thygesen K. Myocardial infarction type 2 and myocardial injury. Clin Chem. 2017;63(1):101–107. doi:10.1373/clinchem.2016.255521
  • Chapman AR, Adamson PD, Shah A, et al. High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation. 2020;141(3):161–171. doi:10.1161/CIRCULATIONAHA.119.042960
  • Jiang Z, Hu P, Liu J, Wang D, Jin L, Hong C. Screening preoperative peptide biomarkers for predicting postoperative myocardial infarction after coronary artery bypass grafting. PLoS One. 2014;9(6):e100149. doi:10.1371/journal.pone.0100149
  • McCarthy CP, Raber I, Chapman AR, et al. Myocardial injury in the era of high-sensitivity cardiac troponin assays: a practical approach for clinicians. JAMA Cardiol. 2019;4(10):1034–1042. doi:10.1001/jamacardio.2019.2724
  • Iddagoda MT. The role of high-sensitive troponin measurement as a biomarker during the postoperative period for the detection of myocardial injury after non-cardiac surgery. J Perioper Pract. 2020;1750458920930993. doi:10.1177/1750458920930993
  • Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem. 2017;63(1):73–81. doi:10.1373/clinchem.2016.255109
  • Kavsak PA, Pardhan A, Krizmanich W, Worster A. Hospital admission and myocardial injury prevalence after the clinical introduction of a high-sensitivity cardiac troponin I assay. Clin Chem. 2015;61(9):1209–1210. doi:10.1373/clinchem.2015.243345
  • Mullins KE, Christenson RH. Optimal detection of acute myocardial injury and infarction with cardiac troponin: beyond the 99th percentile, into the high-sensitivity era. Curr Cardiol Rep. 2020;22(9):101. doi:10.1007/s11886-020-01350-w
  • Thygesen K, Alpert JS, Jaffe ASet al. Fourth universal definition of myocardial infarction (2018). Rev Esp Cardiol. 2019;72(1):72.
  • Omland T. New sensitive cardiac troponin assays for the early diagnosis of myocardial infarction. Drugs Today. 2011;47(4):303–312. doi:10.1358/dot.2011.47.4.1533082
  • Maynard SJ, Menown IB, Adgey AA. Troponin T or troponin I as cardiac markers in ischaemic heart disease. Heart. 2000;83(4):371–373. doi:10.1136/heart.83.4.371
  • Hetland O, Dickstein K. Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting. Clin Chem. 1998;44(7):1430–1436. doi:10.1093/clinchem/44.7.1430
  • Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 1999;99(13):1671–1677. doi:10.1161/01.CIR.99.13.1671
  • Hammarsten O, Mair J, Möckel M, Lindahl B, Jaffe AS. Possible mechanisms behind cardiac troponin elevations. Biomarkers. 2018;23(8):725–734. doi:10.1080/1354750X.2018.1490969
  • Mair J, Lindahl B, Hammarsten O, et al. How is cardiac troponin released from injured myocardium. Eur Heart J Acute Cardiovasc Care. 2018;7(6):553–560. doi:10.1177/2048872617748553
  • Filizcan U, Kurc E, Cetemen S, et al. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology. 2011;62(1):68–73. doi:10.1177/0003319710369103
  • Garg P, Morris P, Fazlanie AL, et al. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017;12(2):147–155. doi:10.1007/s11739-017-1612-1
  • Paparella D, Scrascia G, Paramythiotis A, et al. Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction. Ann Thorac Surg. 2010;89(3):696–702. doi:10.1016/j.athoracsur.2009.11.072
  • Søraas CL, Friis C, Engebretsen KV, Sandvik L, Kjeldsen SE, Tønnessen T. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J. 2012;164(5):779–785. doi:10.1016/j.ahj.2012.05.027
  • Lurati Buse GA, Koller MT, Grapow M, et al. 12-month outcome after cardiac surgery: prediction by troponin T in combination with the European system for cardiac operative risk evaluation. Ann Thorac Surg. 2009;88(6):1806–1812. doi:10.1016/j.athoracsur.2009.07.080
  • Fellahi JL, Le Manach Y, Daccache G, Riou B, Gérard JL, Hanouz JL. Combination of EuroSCORE and cardiac troponin I improves the prediction of adverse outcome after cardiac surgery. Anesthesiology. 2011;114(2):330–339. doi:10.1097/ALN.0b013e318201662f
  • Hu B, Gao F, Lv M, et al. Effects of peak time of myocardial injury biomarkers on mid-term outcomes of patients undergoing OPCABG. BMC Cardiovasc Disord. 2021;21(1):208. doi:10.1186/s12872-021-02006-5
  • Mueller M, Vafaie M, Biener M, Giannitsis E, Katus HA. Cardiac troponin T: from diagnosis of myocardial infarction to cardiovascular risk prediction. Circ J. 2013;77(7):1653–1661. doi:10.1253/circj.CJ-13-0706
  • Hernández-Romero D, Vílchez JA, Lahoz Á, et al. High-sensitivity troponin T as a biomarker for the development of atrial fibrillation after cardiac surgery. Eur J Cardiothorac Surg. 2014;45(4):733–738. doi:10.1093/ejcts/ezt488
  • Markman PL, Tantiongco JP, Bennetts JS, Baker RA. High-sensitivity troponin release profile after cardiac surgery. Heart Lung Circ. 2017;26(8):833–839. doi:10.1016/j.hlc.2016.09.017
  • Mauermann E, Bolliger D, Fassl J, et al. Association of troponin trends and cardiac morbidity and mortality after on-pump cardiac surgery. Ann Thorac Surg. 2017;104(4):1289–1297. doi:10.1016/j.athoracsur.2017.03.003
  • Bandstein N, Wikman A, Ljung R, Holzmann MJ. Survival and resource utilization in patients with chest pain evaluated with cardiac troponin T compared with high-sensitivity cardiac troponin T. Int J Cardiol. 2017;245:43–48. doi:10.1016/j.ijcard.2017.05.111
  • Gahl B, Göber V, Odutayo A, et al. Prognostic value of early postoperative troponin T in patients undergoing coronary artery bypass grafting. J Am Heart Assoc. 2018;7(5):e007743. doi:10.1161/JAHA.117.007743
  • Ståhle E, Bergström R, Holmberg L, Nyström SO, Hansson HE. Risk factors for operative mortality and morbidity in patients undergoing coronary artery bypass surgery for stable angina pectoris. Eur Heart J. 1991;12(2):162–168. doi:10.1093/oxfordjournals.eurheartj.a059863